Abstract
The liver has adapted to the inflow of ingested toxins by the evolutionary development of unique self-regenerative properties and responds to injury or tissue loss by rapid restoration of the original organ mass. This high regenerative capacity is sufficient to restore normal volume and function in most forms of acute liver injury and medical interventions are not required. Regenerative therapies in hepatology rather aim to enhance repair mechanisms of the liver in situations, where the capacity to regenerate is severely impaired. Alternatively, regenerative technologies are applied to solve so far unmet medical needs. The development of such therapies requires a fundamental understanding of the (patho-) physiology of the liver. In this chapter we discuss the emerging medical approaches for acute liver failure, chronic liver failure and hereditary liver diseases, which are based on technologies such as (stem) cell therapy, tissue engineering, bio-artificial devices or gene therapies. Translation from the laboratory bench into routine clinical applications will also require consideration of the legal framework for “advanced therapy medicinal products” (ATMP) as well as “state of the art” manufacturing (GMP) and good clinical practice (GCP) guidelines.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexandrova K, Griesel C, Barthold M et al (2005) Large-scale isolation of human hepatocytes for therapeutic application. Cell Transplant 14:845–853
Alison MR, Lovell MJ (2005) Liver cancer: the role of stem cells. Cell Prolif 38:407–421
Alison M, Golding M, Lalani EN, Nagy P, Thorgeirsson S, Sarraf C (1997) Wholesale hepatocytic differentiation in the rat from ductular oval cells, the progeny of biliary stem cells. J Hepatol 26:343–352
Alison MR, Poulsom R, Jeffery R et al (2000) Hepatocytes from non-hepatic adult stem cells. Nature 406:257
Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM et al (2003) Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425:968–973
am Esch JS 2nd, Knoefel WT, Klein M et al (2005) Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 23(4):463–470
Amado RG, Chen IS (1999) Lentiviral vectors – the promise of gene therapy within reach. Science 285:674–676
Ambrosino G, Varotto S, Strom SC, Guariso G, Franchin E, Miotto D et al (2005) Isolated hepatocyte transplantation for Crigler–Najjar syndrome type 1. Cell Transplant 14:151–157
Asonuma K, Gilbert JC, Stein JE, Takeda T, Vacanti JP (1992) Quantitation of transplanted hepatic mass necessary to cure the Gunn rat model of hyperbilirubinemia. J Pediatr Surg 27:298–301
Aurich I, Mueller LP, Aurich H et al (2007) Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut 56(3):405–415
Bardelli A et al (1996) HGF receptor associates with anti-apoptotic protein BAG-1 and prevents cell death. EMBO J 15:6205–6212
Berardis S, Lombard C, Evraerts J et al (2014) Gene expression profiling and secretome analysis differentiate adult-derived human liver stem/progenitor cells and human hepatic stellate cells. PLoS One 9:e86137
Bey H, Abina S, von Kalle C et al (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348:255–256
Bilir BM, Guinette D, Karrer F et al (2000) Hepatocyte transplantation in acute liver failure. Liver Transpl 6:32–40
Bissig KD, Le TT, Woods NB, Verma IM (2007) Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proc Natl Acad Sci U S A 104(51):20507–20511
Boiani M, Scholer HR (2005) Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 6:872–884
Borkham-Kamphorst E, Kovalenko E, van Roeyen CR, Gassler N, Bomble M et al (2008) Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury. Lab Invest 88(10):1090–1100
Boros P, Miller CM (1995) Hepatocyte growth factor: a multifunctional cytokine. Lancet 345:293–295
Branchereau S, Calise D, Ferry N (1994) Factors influencing retroviral-mediated gene transfer into hepatocytes in vivo. Hum Gene Ther 5:803–808
Burt AD, Portmann BC, Ferrell LD (2007) MacSween’s pathology of the liver. Elsevier, Philadelphia
Cahan P, Li H, Morris SA et al (2014) Cell net: network biology applied to stem cell engineering. Cell 158:903–915
Cai J, Ito M, Nagata H et al (2002) Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes. Hepatology 36:386–394
Cantz T, Sharma AD, Jochheim-Richter A et al (2004) Reevaluation of bone marrow-derived cells as a source for hepatocyte regeneration. Cell Transplant 13:659–666
Cardinale V, Wang Y, Carpino G et al (2011) Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology 54:2159–2172
Cardinale V, Wang Y, Carpino G et al (2012) The biliary tree: a reservoir of multipotent stem cells. Nat Rev Gastroenterol Hepatol 9:231–240
Chen L, Woo SL (2005) Complete and persistent phenotypic correction of phenylketonuria in mice by site-specific genome integration of murine phenylalanine hydroxylase cDNA. Proc Natl Acad Sci U S A 102:15581–15586
Coura Rdos S, Nardi NB (2007) The state of the art of adeno-associated virus-based vectors in gene therapy. Virol J 4:99
Crooke RM, Graham MJ, Lemonidis KM, Whipple CP, Koo S, Perera RJ (2005) An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis. J Lipid Res 46:872–884
Dandri M, Burda MR, Török E, Pollok JM, Iwanska A, Sommer G, Rogiers X, Rogler CE, Gupta S, Will H, Greten H, Petersen J (2001) Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 33(4):981–988
Demetriou AA, Brown RS Jr, Busuttil RW (2004) Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 239:660–667
Dhawan A, Mitry RR, Hughes RD, Lehec S, Terry C, Bansal S et al (2004) Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 78:1812–1814
Dhawan A, Mitry RR, Hughes RD (2006) Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis 29:431–435
Di Campli C, Zocco MA, Saulnier N, Grieco A, Rapaccini G, Addolorato G, Rumi C, Santoliquido A, Leone G, Gasbarrini G, Gasbarrini A (2007) Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure. Dig Liver Dis 39:1071–1076
Di Natale P, Di Domenico C, Gargiulo N et al (2005) Treatment of the mouse model of mucopolysaccharidosis type IIIB with lentiviral-NAGLU vector. Biochem J 388:639–646
Dobbelaere D, Semts F, McKiernam P et al (2014) Phase I/II multicenter trial of liver derived mesenchymal stem cells (HepastemR) for the treatment of urea cycle disorder and Crigler Najjar syndrome. Interim analysis at 6 months post infusion. Society for the Study of Inborn Errors of Metabolism (SSIEM) – annual symposium. Innsbruck J Inherit Metab Dis 37:S34
Drobinskaya I, Linn T, Saric T, Bretzel RG, Bohlen H, Hescheler J, Kolossov E (2008) Scalable selection of hepatocyte- and hepatocyte precursor-like cells from culture of differentiating transgenically modified murine embryonic stem cells. Stem Cells 26(9):2245–2256
Du Y, Wang J, Jia J et al (2014) Human hepatocytes with drug metabolic function inducedfrom fibroblasts by lineage reprogramming. Cell Stem Cell 14:394–403
Duncan AW, Dorrell C, Grompe M (2009) Stem cells and liver regeneration. Gastroenterology 137(2):466–481
Ellis AJ, Hughes RD, Nicholl D (1999) Temporary extracorporeal liver support for severe acute alcoholic hepatitis using BioLogic-DT. Int J Artif Organs 22:27–34
Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292(5819):154–156
Fang B, Shi M, Liao L et al (2004) Systemic infusion of FLK1(_) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 78:83–88
Fausto N (2004) Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 39:1477–1487
Fausto N, Campbell JS (2003) The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 120:117–130
Fausto N, Campbell JS, Riehle KJ (2006) Liver regeneration. Hepatology 43:S45–S53
Fellous TG, Islam S, Tadrous PJ et al (2009) Locating the stem cell niche and tracing hepatocyte lineages in human liver. Hepatology 49(5):1655–1663
Fisher RA, Strom SC (2006) Human hepatocyte transplantation: worldwide results. Transplantation 82:441–449
Fitzpatrick E, Mitry RR, Dhawan A (2009) Human hepatocyte transplantation: state of the art. J Intern Med 266(4):339–357
Fox IJ, Chowdhury JR, Kaufman SS et al (1998) Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338:1422–1426
Furuyama K, Kawaguchi Y, Akiyama H et al (2011) Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 43:34–41
Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M (2009) Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85(8):348–362
Gaia S, Smedile A, Omede P et al (2006) Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 45:13–19
Gao G, Lu Y, Calcedo R et al (2006) Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates. Mol Ther 13:77–87
Garg V, Garg H, Khan A, Trehanpati N, Kumar A, Sharma BC, Sakhuja P, Sarin SK (2012) Granulocyte-colony stimulating factor mobilizes CD34+ cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology 142:505–512
Ghosh SS, Gopinath P, Ramesh A (2006a) Adenoviral vectors: a promising tool for gene therapy. Appl Biochem Biotechnol 133:9–29
Ghosh A, Allamarvdasht M, Pan CJ et al (2006b) Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer. Gene Ther 13:321–329
Gordon MY, Levicar N, Pai M et al (2006) Characterisation and clinical application of human CD34_ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 24:1822–1830
Gorla GR, Malhi H, Gupta S (2001) Polyploidy associated with oxidative injury attenuates proliferative potential of cells. J Cell Sci 114:2943–2951
Gouon-Evans V, Boussemart L, Gadue P et al (2006) BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol 24:1402–1411
Grieger JC, Samulski RJ (2005) Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Adv Biochem Eng Biotechnol 99:119–145
Grompe M, Overturf K, al Dhalimy M, Finegold M (1998) Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report. J Inherit Metab Dis 21:518–531
Habibullah CM, Syed IH, Qamar A, Taher-Uz Z (1994) Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 58(8):951–952
Haridass D, Yuan Q, Becker PD et al (2009) Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice. Am J Pathol 175(4):1483–1492
Heo J, Factor VM, Uren T, Takahama Y, Lee JS, Major M, Feinstone SM, Thorgeirsson SS (2006) Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. Hepatology 44:1478–1486
Herzog RW, Yang EY, Couto LB et al (1999) Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 5:56–63
Herzog EL, Chai L, Krause DS (2003) Plasticity of marrow-derived stem cells. Blood 102:3483–3493
Horslen SP, McCowan TC, Goertzen TC et al (2003) Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111:1262–1267
Houlihan DD, Newsome PN (2008) Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 135:438–450
Howden SE, Voullaire L, Vadolas J (2007) The transient expression of mRNA coding for Rep protein from AAV facilitates targeted plasmid integration. J Gene Med 10:42–50
Huang P, He Z, Ji S, Sun H, Xiang D, Liu C, Hu Y, Wang X, Hui L (2011) Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 475(7356):386–389
Huang P, Zhang L, Gao Y et al (2014) Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell 14:370–384
Huch M, Dorrell C, Boj SF et al (2013) In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature 494:247–250
Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen MM, Ellis E, van Wenum M, Fuchs SA, de Ligt J, van de Wetering M, Sasaki N, Boers SJ, Kemperman H, de Jonge J, Ijzermans JN, Nieuwenhuis EE, Hoekstra R, Strom S, Vries RR, van der Laan LJ, Cuppen E, Clevers H (2015) Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160(1–2):299–312
Hughes RD, Mitry RR, Dhawan A (2005) Hepatocyte transplantation for metabolic liver disease: UK experience. J R Soc Med 98:341–345
Jager L, Ehrhardt A (2007) Emerging adenoviral vectors for stable correction of genetic disorders. Curr Gene Ther 7:272–283
Jalan R, Wright G, Davies NA, Hodges SJ (2007) L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy. Med Hypotheses 69:1064–1069
Jungermann K, Kietzmann T (2000) Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 31(2):255–260
Kanazawa Y, Verma IM (2003) Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver. Proc Natl Acad Sci U S A 100(Suppl 1):11850–11853
Khan AA, Parveen N, Mahaboob VS et al (2008) Treatment of Crigler-Najjar Syndrome type 1 by hepatic progenitor cell transplantation: a simple procedure for management of hyperbilirubinemia. Transplant Proc 40(4):1148–1150
Khuroo MS, Khuroo MS, Farahat KL (2004) Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis. Liver Transpl 10:1099–1106
Kim IH, Jozkowicz A, Piedra PA, Oka K, Chan L (2001) Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci U S A 98:13282–13287
Kisseleva T, Uchinami H, Feirt N et al (2006) Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 45:429–438
Kobayashi N, Ito M, Nakamura J et al (2000) Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology 31:851–857
Kobayashi H, Carbonaro D, Pepper K et al (2005) Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector. Mol Ther 11:776–789
Kramer L (2000) Clinical experience with artifical liver support in chronic liver failure with encephalopathy. ASAIO J 46:a211
Kribben A, Gerken G, Haag S et al (2012) Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology 142:782–789
Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, Wang X, Finegold M, Weissman IL, Grompe M (2000) Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6:1229–1234
Lancaster MA, Knoblich JA (2014) Organogenesis in a dish: modeling development and disease using organoid technologies. Science 345(6194):1247125
Lanzoni G, Oikawa T, Wang Y et al (2013) Concise review: clinical programs of stem cell therapies for liver and pancreas. Stem Cells 31:2047–2060
Levicar N, Pai M, Habib NA et al (2008) Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34_ cells in patients with chronic liver disease. Cell Prolif 41:115–125
Li W, Wang D, Qin J et al (2010) Generation of functional hepatocytes from mouse induced pluripotent stem cells. J Cell Physiol 222:492–501
Lyra AC, Soares MB, da Silva LF et al (2007a) Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol 13:1067–1073
Lyra AC, Soares MB, da Silva LF et al (2007b) A pilot randomised controlled study usd to evaluate efficacy of autologous bone marrow mononuclear cells transplantation in patients with advanced chronic liver disease (abstr). Hepatology 46(Suppl 1):271A
Malato Y, Naqvi S, Schurmann N et al (2011) Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J Clin Invest 121:4850–4860
Manno CS, Pierce GF, Arruda VR et al (2006) Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 12:342–347
Marshall E (1999) Gene therapy death prompts review of adenovirus vector. Science 286:2244–2245
Marshall A, Rushbrook S, Davies SE et al (2005) Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology 128:33–42
Mazariegos GV, Kramer DJ, Lopez RC (2001) Safety observations in phase I clinical evaluation of the Excorp Medical bioartificial liver support system after the first four patients. ASAIO J 47:471–475
Merle U, Encke J, Tuma S, Volkmann M, Naldini L, Stremmel W (2006) Lentiviral gene transfer ameliorates disease progression in Long-Evans cinnamon rats: an animal model for Wilson disease. Scand J Gastroenterol 41:974–982
Meyburg J, Das AM, Hoerster F et al (2009) One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects. Transplantation 87(5):636–641
Miao CH, Thompson AR, Loeb K, Ye X (2001) Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo. Mol Ther 3:947–957
Michalopoulos GK, DeFrances MC (1997) Liver regeneration. Science 276:60–66
Mingozzi F, High KA (2007) Immune responses to AAV in clinical trials. Curr Gene Ther 7:316–324
Mishra L, Banker T, Murray J et al (2009) Liver stem cells and hepatocellular carcinoma. Hepatology 49(1):318–329
Mitry RR, Dhawan A, Hughes RD, Bansal S, Lehec S, Terry C et al (2004) One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation 77:1614–1616
Mitzner SR, Stange J, Klammt S, Koball S, Hickstein H, Reisinger EC (2009) Albumin dialysis MARS: knowledge from 10 years of clinical investigation. ASAIO J 55(5):498–502
Miyazawa K et al (1989) Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 163:967–973
Möbus S, Yang D, Yuan Q et al (2015) MicroRNA-199a-5p inhibition enhances the liver repopulation ability of human embryonic stem cell-derived hepatic cells. J Hepatol 62:101–110
Mohamadnejad M, Namiri M, Bagheri M et al (2007a) Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 28:3359–3363
Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M et al (2007b) Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 10:459–466
Morris SA, Cahan P, Li H et al (2014) Dissecting engineered cell types and enhancing cell fate conversion via cell net. Cell 158:889–902
Muir AJ, Sylvestre PB, Rockey DC (2006) Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection. J Viral Hepat 13(5):322–328
Muraca M, Gerunda G, Neri D, Vilei MT, Granato A, Feltracco P et al (2002) Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 359:317–318
Najimi M, Khuu DN, Lysy PA et al (2007) Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes? Cell Transplant 16:717–728
Nakamura T, Nawa K, Ichihara A (1984) Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122:1450–1459
Nakamura T et al (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440–443
Nakamura T, Torimura T, Sakamoto M et al (2007) Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. Gastroenterology 133:91–107
Nathwani AC, Tuddenham EG, Rangarajan S et al (2011) Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 365(25):2357–2365
Nathwani AC, Reiss UM, Tuddenham EG et al (2014) Long-term safety and efficacy of factor IX gene therapy in hemophilia B. N Engl J Med 371(21):1994–2004
Nussler A, Konig S, Ott M et al (2006) Present status and perspectives of cell-based therapies for liver diseases. J Hepatol 45:144–159
Ohashi K, Yokoyama T, Yamato M, Kuge H, Kanehiro H, Tsutsumi M, Amanuma T, Iwata H, Yang J, Okano T, Nakajima Y (2007) Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets. Nat Med 13(7):880–885
Ohashi K, Koyama F, Tatsumi K et al (2009) Functional life-long maintenance of engineered liver tissue in mice following transplantation under the kidney capsule. J Tissue Eng Regen Med 4:141–148
Oka K, Belalcazar LM, Dieker C et al (2007) Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector. Gene Ther 14:191–202
Overturf K, Al Dhalimy M, Tanguay R et al (1996) Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Genet 12:266–273
Overturf K, al-Dhalimy M, Ou CN, Finegold M, Grompe M (1997a) Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 151:1273–1280
Overturf K, Al Dhalimy M, Ou CN et al (1997b) Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I. Hum Gene Ther 8:513–521
Oyagi S, Hirose M, Kojima M et al (2006) Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4- injured rats. J Hepatol 44:742–748
Pai M, Zacharoulis D, Milicevic MN, Helmy S, Jiao LR et al (2008) Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 103:1952–1958
Peng Z (2005) Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers. Hum Gene Ther 16:1016–1027
Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, Goff JP et al (1999) Bone marrow as a potential source of hepatic oval cells. Science 284:1168–1170
Pockros PJ, Jeffers L, Afdhal N, Goodman ZD, Nelson D et al (2007) Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis. Hepatology 45(3):569–578
Ponder KP, Melniczek JR, Xu L et al (2002) Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs. Proc Natl Acad Sci U S A 99:13102–13107
Poyck PP, van Wijk AC, van der Hoeven TV et al (2008) Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver. J Hepatol 48(2):266–275
Quante M, Wang TC (2009) Stem cells in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 6(12):724–737
Quintana-Bustamante O, Alvarez-Barrientos A, Kofman AV et al (2006) Hematopoietic mobilization in mice increases the presence of bone marrow-derived hepatocytes via in vivo cell fusion. Hepatology 43:108–116
Raper SE, Wilson JM, Yudkoff M, Robinson MB, Ye X, Batshaw ML (1998) Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency. J Inherit Metab Dis 21(Suppl 1):119–137
Rathjen J, Rathjen PD (2001) Mouse ES cells: experimental exploitation of pluripotent differentiation potential. Curr Opin Genet Dev 11:587–594
Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending directive 2001/83/EC and regulation (EC) No 726/2004. Official Journal of the European Union (10.12. 2007) L324/121
Rettinger SD, Ponder KP, Saylors RL, Kennedy SC, Hafenrichter DG, Flye MW (1993) In vivo hepatocyte transduction with retrovirus during in-flow occlusion. J Surg Res 54:418–425
Rifai K, Ernst T, Kretschmer U (2003) Prometheus: a new extracorporeal system for the treatment of liver failure. J Hepatol 39:984–990
Roskams T (2006) Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 25(27):3818–3822
Roskams T, Yang SQ, Koteish A et al (2003) Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 163:1301–1311
Russell WE, Mcgowan JA, Bucher NL (1984) Partial characterization of a hepatocyte growth factor from platelets. J Cell Physiol 119:183–192
Russo FP, Alison MR, Bigger BW et al (2006) The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130:1807–1821
Sabatino DE, Mackenzie TC, Peranteau W et al (2007) Persistent expression of hF.IX after tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice. Mol Ther 15:1677–1685
Sackett SD, Li Z, Hurtt R et al (2009) Foxl1 is a marker of bipotential hepatic progenitor cells in mice. Hepatology 49:920–929
Sakaida I, Terai S, Yamamoto N et al (2004) Transplantation of bone marrow cells reduces CCL4-induced liver fibrosis in mice. Hepatology 40:1304–1311
Saliba F, Camus C, Durand F et al (2009) Predictive factors of transplant free survival in patients with fulminant and subfulminant hepatic failure: results from a randomized controlled multicenter trial. J Hepatol 50(Suppl 1):S89–S90
Samulski RJ, Zhu X, Xiao X et al (1991) Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J 10:3941–3950
Santoro A, Faenza S, Mancini E (2006) Prometheus system: a technological support in liver failure. Transplant Proc 38:1078–1082
Sauer IM, Kardassis D, Zeillinger K (2003) Clinical extracorporeal hybrid liver support: phase I study with primary porcine liver cells. Xenotransplantation 10:460–469
Schaub JR, Malato Y, Gormond C et al (2014) Evidence against a stem cell origin of new hepatocytes in a common mouse model of chronic liver injury. Cell Rep 8:933–939
Schiff ER, Sorrell MF, Maddrey WC (2007) Schiff’s diseases of the liver. Lippincott Williams & Wilkins, Philadelphia
Schmidt C et al (1995) Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373:699–702
Schneider A, Attaran M, Meier PN et al (2006) Hepatocyte transplantation in acute liver failure due to mushroom poisoning. Transplantation 82:1115–1116
Sekiya S, Suzuki A (2011) Direct conversion of mouse fibroblasts tohepatocyte-like cells by defined factors. Nature 475(7356):390–393
Seppen J, van der Rijt R, Looije N, van Til NP, Lamers WH, Oude Elferink RP (2003) Long-term correction of bilirubin UDP glucuronyltransferase deficiency in rats by in utero lentiviral gene transfer. Mol Ther 8:593–599
Sherlock S, Dooley J (2002) Disease of the liver and biliary system. Blackwell Publishing Company, Oxford
Shin S, Walton G, Aoki R et al (2011) Foxl1-Cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potential. Genes Dev 25:1185–1192
Sigal SH, Brill S, Fiorino AS et al (1992) The liver as a stem cell and lineage system. Am J Physiol 263:G139–G148
Sigal SH, Gupta S, Gebhard DF Jr, Holst P, Neufeld D, Reid LM (1995) Evidence for a terminal differentiation process in the rat liver. Differentiation 59:35–42
Siller–Lopez F, Sandoval A, Salgado S, Salazar A, Bueno M (2004) Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. Gastroenterology 126:1122–1133
Sinn PL, Sauter SL, McCray PB Jr (2005) Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors – design, biosafety, and production. Gene Ther 12:1089–1098
Si-Tayeb K, Noto FK, Nagaoka M et al (2010) Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51:297–305
Sokal EM, Smets F, Bourgois A, Van Maldergem L, Buts JP, Reding R et al (2003) Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 76:735–738
Sokal EM, Stephenne X, Ottolenghi C et al (2014) Liver engraftment and repopulation by in vitro expanded adult derived human liver stem cells in a child with ornithine carbamoyltransferase deficiency. JIMD Rep 13:65–72
Song Z, Cai J, Liu Y et al (2009) Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 19:1233–1242
Song G, Sharma AD, Roll GR, Ng R, Lee AY, Blelloch RH, Frandsen NM, Willenbring H (2010) MicroRNAs control hepatocyte proliferation during liver regeneration. Hepatology 51:1735–1743
Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K (2008) Induced pluripotent stem cells generated without viral integration. Science 322:945–949
Stange J, Mitzner S, Risler T (1999) Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 23:319–330
Steiner C, Sen S, Stange J, Williams R, Jalan R (2004) Binding of bilirubin and bromosulphthalein to albumin: implications for understanding the pathophysiology of liver failure and its management. Liver Transpl 10:1531–1538
Stephenne X, Najimi M, Smets F, Reding R, de Ville de Goyet J, Sokal EM (2005) Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am J Transplant 5:2058–2061
Stephenne X, Najimi M, Sibille C, Nassogne MC, Smets F, Sokal EM (2006) Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology 130:1317–1323
Strom SC, Fisher RA, Thompson MT et al (1997) Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 63:559–569
Stutchfield BM, Rashid S, Forbes SJ, Wigmore SJ (2010) Practical barriers to delivering autologous bone marrow stem cell therapy as an adjunct to liver resection. Stem Cells Dev 19:155–162
Sullivan GJ, Hay DC, Park IH et al (2010) Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 51:329–335
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872
Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, Zhang RR et al (2013) Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499:481–484
Takezawa R, Watanabe Y, Akaike T (1995) Direct evidence of macrophage differentiation from bone marrow cells in the liver: a possible origin of Kupffer cells. J Biochem (Tokyo) 118:1175–1183
Taniguchi E, Kin M, Torimura T et al (2006) Endothelial progenitor cell transplantation improves the survival following liver injury in mice. Gastroenterology 130:521–531
Tarlow BD, Finegold MJ, Grompe M (2014) Clonal tracing of Sox9+ liver progenitors in mouse oval cell injury. Hepatology 60:278–289
Taub R (1996) Liver regeneration 4: transcriptional control of liver regeneration. FASEB J 10(4):413–427
Taub R (2004) Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 5(10):836–847
Terai S, Ishikawa T, Omori K et al (2006) Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 24:2292–2298
Theise ND, Badve S, Saxena R, Henegariu O, Sell S, Crawford JM, Krause DS (2000) Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 31:235–240
Thieringer F, Maass T, Czochra P, Klopcic B, Conrad I et al (2008) Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A. Gene 423(1):23–28
Thomson JA, Itskovitz-Eldor J, Shapiro SS et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145–1147
Thorgeirsson SS (1996) Hepatic stem cells in liver regeneration. FASEB J 10:1249–1256
Tominaga K, Kuriyama S, Yoshiji H et al (2004) Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies. Gut 53:1167–1173
Touboul T, Hannan NR, Corbineau S et al (2010) Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology 51(5):1754–1765
Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y et al (1999) Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 5(2):226–230
Ueno T, Nakamura T, Torimura T et al (2006) Angiogenic cell therapy for hepatic fibrosis. Med Mol Morphol 39:16–21
Van De Kerkhove MP, Di Florio E, Scuderi V (2002) Phase I clinical trial with the AMC-bioartificial liver. Int J Artif Organs 25:950
Vassilopoulos G, Wang PR, Russell DW (2003) Transplanted bone marrow regenerates liver by cell fusion. Nature 422:901–904
Waddington SN, Nivsarkar MS, Mistry AR et al (2004) Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. Blood 104:2714–2721
Wagers AJ, Sherwood RI, Christensen JL, Weissman IL (2002) Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297:2256–2259
Wang X, Willenbring H, Akkari Y et al (2003) Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422:897–901
Wiemann SU, Satyanarayana A, Tsahuridu M et al (2002) Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J 16:935–942
Willenbring H, Bailey AS, Foster M et al (2004) Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat Med 10:744–748
Wu Z, Asokan A, Samulski RJ (2006) Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol Ther 14:316–327
Wu G, Liu N, Rittelmeyer I, Sharma AD, Sgodda M, Zaehres H, Bleidissel M, Greber B, Gentile L, Han DW, Rudolph C, Steinemamm D, Schambach A, Ott M, Schöler HR, Cantz T (2011) Generation of healthy mice from gene-corrected disease-specific induced pluripotent stem cells. PLoS Biol 9(7):e1001099
Yanger K, Knigin D, Zong Y et al (2014) Adult hepatocytes are generated by self-duplication rather than stem cell differentiation. Cell Stem Cell 15:340–349
Yannaki E, Anagnostopoulos A, Kapetanos D et al (2006) Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp Hematol 34:1583–1587
Ye P, Thompson AR, Sarkar R et al (2004) Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice. Mol Ther 10:117–126
Yimlamai D, Christodoulou C, Galli GG et al (2014) Hippo pathway activity influences liver cell fate. Cell 157:1324–1338
Yiu WH, Pan CJ, Allamarvdasht M, Kim SY, Chou JY (2007) Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice. Gene Ther 14:219–226
Young SM Jr, McCarty DM, Degtyareva N, Samulski RJ (2000) Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination. J Virol 74:3953–3966
Yuan Q, Loya K, Rani B, Möbus S, Balakrishnan A, Lamle J, Cathomen T, Vogel A, Manns MP, Ott M, Cantz T, Sharma AD (2013) MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration. Hepatology 57:299–310
Zhao DC, Lei JX, Chen R et al (2005) Bone marrow derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol 11:3431–3440
Zhu S, Rezvani M, Harbell J et al (2014) Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature 508:93–97
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Cantz, T., Sharma, A.D., Manns, M.P., Ott, M. (2016). Liver. In: Steinhoff, G. (eds) Regenerative Medicine - from Protocol to Patient. Springer, Cham. https://doi.org/10.1007/978-3-319-28386-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-28386-9_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28384-5
Online ISBN: 978-3-319-28386-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)